ÍøºìºÚÁÏ

The purpose of this study is to evaluate the efficacy and safety of treatment with subcutaneous anifrolumab versus placebo in adult participants with systemic sclerosis. The target population for this study includes patients who meet the 2013…

Investigator

Michael R Bubb

Status

Accepting Candidates

Ages

18 Years - 70 Years

Sexes

All

Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems. This study will assess how safe and effective upadacitinib is in treating adult participants with moderately to severely active…

Investigator

Michael R Bubb

Status

Accepting Candidates

Ages

18 Years - 63 Years

Sexes

All

The purpose of this study is to measure the long-term safety and tolerability of efgartigimod PH20 SC in adult participants with IIM who previously participated in ARGX-113-2007. Secondary objectives include efficacy measures of efgartigimod PH20 SC…

Investigator

Michael R Bubb

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

All